Grading of neurological toxicity in patients treated with tisagenlecleucel in the JULIET trial

Lignende værker

• Grading and management of cytokine release syndrome in patients treated with tisagenlecleucel in the JULIET trial
  af: Schuster, Stephen J., et al.
  Udgivet: (2020)
• Real-world evidence of tisagenlecleucel for pediatric acute lymphoblastic leukemia and non-Hodgkin lymphoma
  af: Pasquini, Marcelo C., et al.
  Udgivet: (2020)
• Patient-reported long-term quality of life after tisagenlecleucel in relapsed/refractory diffuse large B-cell lymphoma
  af: Maziarz, Richard T., et al.
  Udgivet: (2020)
• Tisagenlecleucel CAR T-cell therapy in secondary CNS lymphoma
  af: Frigault, Matthew J., et al.
  Udgivet: (2019)
• Comparing CAR T-cell toxicity grading systems: application of the ASTCT grading system and implications for management
  af: Pennisi, Martina, et al.
  Udgivet: (2020)